Treatment of Concurrent Depression and Its Effect on Outcomes After Total Joint Arthroplasty: A Systematic Review of Comparative Studies.
Journal
The Journal of the American Academy of Orthopaedic Surgeons
ISSN: 1940-5480
Titre abrégé: J Am Acad Orthop Surg
Pays: United States
ID NLM: 9417468
Informations de publication
Date de publication:
27 Dec 2023
27 Dec 2023
Historique:
received:
23
05
2023
accepted:
27
10
2023
medline:
28
12
2023
pubmed:
28
12
2023
entrez:
28
12
2023
Statut:
aheadofprint
Résumé
There is a growing body of evidence suggesting that patients with a diagnosis of depression suffer worse outcomes after total joint arthroplasty (TJA) procedures. It is unclear whether depression treatment is a modifiable risk factor that can be targeted to improve suboptimal outcomes. We conducted a systematic review to understand the role that various interventions have on outcomes of TJA in patients with diagnosed depression (PDDs). PubMed, Ovid MEDLINE, Scopus, and EMBASE were searched systematically from inception until November 2022. Studies of PDDs who underwent TJA that compared any intervention/treatment of depression with a control group and reported pain, functional outcomes, depression scores, and/or revision rates after TJA were relevant for this review. Ten relevant studies were included in the final systematic review, with a total of 33,501 patients included. Two studies reported lower revision rates for patients receiving selective serotonin reuptake inhibitor treatment and psychotherapy. Two studies showed no difference in functional outcomes for patients receiving pharmacologic treatment. One study reported improved functional outcomes for patients receiving cognitive behavioral therapy and another reported improved postoperative functional outcomes for patients receiving alprazolam. Interventions targeted at PDDs may improve short-term pain and functional outcomes, and there may be an association between selective serotonin reuptake inhibitor use and implant survival. The current literature is limited and inconclusive, with important gaps in understanding regarding the optimization and treatment of this modifiable risk factor. Surgeons should consider depression treatment as a method to improve outcomes in this cohort.
Identifiants
pubmed: 38154094
doi: 10.5435/JAAOS-D-23-00459
pii: 00124635-990000000-00855
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 by the American Academy of Orthopaedic Surgeons.
Références
Daly M, Sutin AR, Robinson E: Depression reported by US adults in 2017-2018 and march and april 2020. J Affect Disord 2021;278:131-135.
Halawi MJ, Gronbeck C, Savoy L, Cote MP, Lieberman JR: Depression treatment is not associated with improved patient-reported outcomes following total joint arthroplasty. J Arthroplasty 2020;35:28-31.
Zhang F, Rao S, Baranova A: Shared genetic liability between major depressive disorder and osteoarthritis. Bone Joint Res 2022;11:12-22.
Oh C, Slover JD, Bosco JA, Iorio R, Gold HT: Time trends in characteristics of patients undergoing primary total hip and knee arthroplasty in California, 2007-2010. J Arthroplasty 2018;33:2376-2380.
Sloan M, Premkumar A, Sheth NP: Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018;100:1455-1460.
Bozic KJ, Lau E, Kurtz S, et al.: Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012;94:794-800.
Kim H, Kim CH: Association between preoperative depression and readmission rate following primary total joint arthroplasty: A systematic review and meta-analysis. J Arthroplasty 2021;36:3807-3813.
Khatib Y, Madan A, Naylor JM, Harris IA: Do psychological factors predict poor outcome in patients undergoing TKA? A systematic review. Clin Orthop Relat Res 2015;473:2630-2638.
Etcheson JI, Gwam CU, George NE, Virani S, Mont MA, Delanois RE: Patients with major depressive disorder experience increased perception of pain and opioid consumption following total joint arthroplasty. J Arthroplasty 2018;33:997-1002.
Bernstein DN, Liu TC, Winegar AL, et al.: Evaluation of a preoperative optimization protocol for primary hip and knee arthroplasty patients. J Arthroplasty 2018;33:3642-3648.
Park LT, Zarate CA Jr.: Clinical practice: Depression in the primary care setting. N Engl J Med 2019;380:2279-2280.
Kazarian GS, Anthony CA, Lawrie CM, Barrack RL: The impact of psychological factors and their treatment on the results of total knee arthroplasty. J Bone Joint Surg Am 2021;103:1744-1756.
Moher D, Shamseer L, Clarke M, et al.: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Revista Espanola de Nutricion Humana y Dietetica, 2016.
Cumpston M, Li T, Page MJ, et al.: Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions, 10. England, Syst Rev, 2019, ED000142.
Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, Vol 372. BMJ, 2021.
Sterne JAC, Savović J, Page MJ, et al.: RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J: Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ J Surg 2003;73:712-716.
Yao JJ, Maradit Kremers H, Kremers WK, Lewallen DG, Berry DJ: Perioperative inpatient use of selective serotonin reuptake inhibitors is associated with a reduced risk of THA and TKA revision. Clin Orthop Relat Res 2018;476:1191-1197.
Kohring JM, Erickson JA, Anderson MB, Gililland JM, Peters CL, Pelt CE: Treated versus untreated depression in total joint arthroplasty impacts outcomes. J Arthroplasty 2018;33:S81-S85.
das Nair R, Mhizha-Murira JR, Anderson P, et al.: Home-based pre-surgical psychological intervention for knee osteoarthritis (HAPPiKNEES): A feasibility randomized controlled trial. Clin Rehabil 2018;32:777-789.
Schwartz AM, Wilson JM, Farley KX, Roberson JR, Guild GN, Bradbury TL: Modifiability of depression's impact on early revision, narcotic usage, and outcomes after total hip arthroplasty: The impact of psychotherapy. J Arthroplasty 2020;35:2904-2910.
Giaquinto S, Cacciato A, Minasi S, Sostero E, Amanda S: Effects of music-based therapy on distress following knee arthroplasty. Br J Nurs 2006;15:576-579.
Lee JK, Zubaidah JO, Fadhilah ISI, Normala I, Jensen MP: Prerecorded hypnotic peri-surgical intervention to alleviate risk of chronic postsurgical pain in total knee replacement: A randomized controlled pilot study. The Int J Clin Exp hypnosis 2019;67:217-245.
Geng X, Wang X, Zhou G, et al.: A randomized controlled trial of psychological intervention to improve satisfaction for patients with depression undergoing TKA: A 2-year follow-up. J Bone Joint Surg Am Volume 2021;103:567-574.
Yılmaz B, Kömür B, Aktaş E, et al.: Impact of alprazolam on comorbid pain and knee functions in total knee arthroplasty patients diagnosed with anxiety and depression. Open Orthop J 2015;9:530-535.
Yao JJ, Maradit Kremers H, Kremers WK, Lewallen DG, Berry DJ: Perioperative inpatient use of selective serotonin reuptake inhibitors is associated with a reduced risk of THA and TKA revision. Clin Orthop Relat Res 2018;476:1191-1197.
Ding Zchuan, Li H, Huang C, et al.: Significant analgesic benefits of perioperative duloxetine in patients who have depressive symptoms undergoing total hip arthroplasty: A randomized controlled trial. J Arthroplasty 2022;522.
Cai L, Gao H, Xu H, Wang Y, Lyu P, Liu Y: Does a program based on cognitive behavioral therapy affect kinesiophobia in patients following total knee arthroplasty? A randomized, controlled trial with a 6-month follow-up. J Arthroplasty 2018;33:704-710.
Filardo G, Merli G, Roffi A, et al.: Kinesiophobia and depression affect total knee arthroplasty outcome in a multivariate analysis of psychological and physical factors on 200 patients. Knee Surg Sports Traumatol Arthrosc 2017;25:3417-3423.
Cai L, Liu Y, Xu H, Xu Q, Wang Y, Lyu P: Incidence and risk factors of kinesiophobia after total knee arthroplasty in Zhengzhou, China: A cross-sectional study. J Arthroplasty 2018;33:2858-2862.
Wu X, Al-Abedalla K, Rastikerdar E, et al.: Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: A cohort study. J Dent Res 2014;93:1054-1061.
Tsapakis EM, Gamie Z, Tran GT, et al.: The adverse skeletal effects of selective serotonin reuptake inhibitors, Vol 27. European Psychiatry, 2012.
Belay ES, Penrose CT, Ryan SP, Bergen MA, Bolognesi MP, Seyler TM: Perioperative selective serotonin reuptake inhibitor use is associated with an increased risk of transfusion in total hip and knee arthroplasty. J Arthroplasty 2019;34:2898-2902.
Bismuth-Evenzal Y, Gonopolsky Y, Gurwitz D, Iancu I, Weizman A, Rehavi M: Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord 2012;136:99-103.
Bourget-Murray J, Parkar A, Railton P, Evaniew N, Powell J: Effects of perioperative selective serotonin reuptake inhibitor use in primary total hip and knee arthroplasty. J Arthroplasty 2022;37:454-459.
Li W, Ayers DC, Lewis CG, Bowen TR, Allison JJ, Franklin PD: Functional gain and pain relief after total joint replacement according to obesity statusThe J Bone Joint Surg Am Vol 2017;99:1183-1189.